FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204043873> ?p ?o ?g. }

• W3204043873 abstract "Abstract Background Dupuytren’s contracture is a fibro-proliferative disease of the hands affecting over 2 million UK adults, particularly the white, male population. Surgery is the traditional treatment; however, recent studies have indicated that an alternative to surgery—collagenase clostridium histolyticum (collagenase)—is better than a placebo in the treatment of Dupuytren’s contracture. There is however no robust randomised controlled trial that provides a definitive answer on the clinical effectiveness of collagenase compared with limited fasciectomy surgery. Dupuytren’s intervention surgery vs collagenase trial (DISC) trial was therefore designed to fill this evidence gap. Methods/design The DISC trial is a multi-centre pragmatic two-arm parallel-group, randomised controlled trial. Participants will be assigned 1:1 to receive either collagenase injection or surgery (limited fasciectomy). We aim to recruit 710 adult participants with Dupuytren’s contracture. Potential participants will be identified in primary and secondary care, screened by a delegated clinician and if eligible and consenting, baseline data will be collected and randomisation completed. The primary outcome will be the self-reported patient evaluation measure assessed 1 year after treatment. Secondary outcome measures include the Unité Rhumatologique des Affections de la Main Scale, the Michigan Hand Questionnaire, EQ-5D-5L, resource use, further procedures, complications, recurrence, total active movement and extension deficit, and time to return to function. Given the limited evidence comparing recurrence rates following collagenase injection and limited fasciectomy, and the importance of a return to function as soon as possible for patients, the associated measures for each will be prioritised to allow treatment effectiveness in the context of these key elements to be assessed. An economic evaluation will assess the cost-effectiveness of treatments, and a qualitative sub-study will assess participants’ experiences and preferences of the treatments. Discussion The DISC trial is the first randomised controlled trial, to our knowledge, to investigate the clinical and cost-effectiveness of collagenase compared to limited fasciectomy surgery for patients with Dupuytren’s contracture. Trial registration Clinical.Trials.gov ISRCTN18254597 . Registered on April 11, 2017." @default.
• W3204043873 created "2021-10-11" @default.
• W3204043873 creator A5000049257 @default.
• W3204043873 creator A5003648550 @default.
• W3204043873 creator A5004176665 @default.
• W3204043873 creator A5004587968 @default.
• W3204043873 creator A5010910747 @default.
• W3204043873 creator A5015708199 @default.
• W3204043873 creator A5015865141 @default.
• W3204043873 creator A5020992463 @default.
• W3204043873 creator A5025848347 @default.
• W3204043873 creator A5036566137 @default.
• W3204043873 creator A5040091556 @default.
• W3204043873 creator A5040295464 @default.
• W3204043873 creator A5041397505 @default.
• W3204043873 creator A5049376976 @default.
• W3204043873 creator A5050863726 @default.
• W3204043873 creator A5050931179 @default.
• W3204043873 creator A5051805189 @default.
• W3204043873 creator A5058644407 @default.
• W3204043873 creator A5060227347 @default.
• W3204043873 creator A5060377511 @default.
• W3204043873 creator A5076754908 @default.
• W3204043873 creator A5085861845 @default.
• W3204043873 date "2021-09-30" @default.
• W3204043873 modified "2023-10-18" @default.
• W3204043873 title "Dupuytren’s interventions surgery versus collagenase (DISC) trial: study protocol for a pragmatic, two-arm parallel-group, non-inferiority randomised controlled trial" @default.
• W3204043873 cites W166560170 @default.
• W3204043873 cites W1785898356 @default.
• W3204043873 cites W1840457638 @default.
• W3204043873 cites W1903682179 @default.
• W3204043873 cites W1964329351 @default.
• W3204043873 cites W1971286645 @default.
• W3204043873 cites W1971796909 @default.
• W3204043873 cites W1979290264 @default.
• W3204043873 cites W1981747359 @default.
• W3204043873 cites W2037324722 @default.
• W3204043873 cites W2053261213 @default.
• W3204043873 cites W2055251975 @default.
• W3204043873 cites W2066436633 @default.
• W3204043873 cites W2070705145 @default.
• W3204043873 cites W2080297249 @default.
• W3204043873 cites W2082908125 @default.
• W3204043873 cites W2086383766 @default.
• W3204043873 cites W2089622036 @default.
• W3204043873 cites W2117364326 @default.
• W3204043873 cites W2151182129 @default.
• W3204043873 cites W2156122530 @default.
• W3204043873 cites W2159759971 @default.
• W3204043873 cites W2186657631 @default.
• W3204043873 cites W2473786944 @default.
• W3204043873 cites W2517953780 @default.
• W3204043873 cites W2611551550 @default.
• W3204043873 cites W2781496155 @default.
• W3204043873 cites W4255033835 @default.
• W3204043873 cites W4317926485 @default.
• W3204043873 doi "https://doi.org/10.1186/s13063-021-05595-w" @default.
• W3204043873 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8481756" @default.
• W3204043873 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34593024" @default.
• W3204043873 hasPublicationYear "2021" @default.
• W3204043873 type Work @default.
• W3204043873 sameAs 3204043873 @default.
• W3204043873 citedByCount "3" @default.
• W3204043873 countsByYear W32040438732022 @default.
• W3204043873 countsByYear W32040438732023 @default.
• W3204043873 crossrefType "journal-article" @default.
• W3204043873 hasAuthorship W3204043873A5000049257 @default.
• W3204043873 hasAuthorship W3204043873A5003648550 @default.
• W3204043873 hasAuthorship W3204043873A5004176665 @default.
• W3204043873 hasAuthorship W3204043873A5004587968 @default.
• W3204043873 hasAuthorship W3204043873A5010910747 @default.
• W3204043873 hasAuthorship W3204043873A5015708199 @default.
• W3204043873 hasAuthorship W3204043873A5015865141 @default.
• W3204043873 hasAuthorship W3204043873A5020992463 @default.
• W3204043873 hasAuthorship W3204043873A5025848347 @default.
• W3204043873 hasAuthorship W3204043873A5036566137 @default.
• W3204043873 hasAuthorship W3204043873A5040091556 @default.
• W3204043873 hasAuthorship W3204043873A5040295464 @default.
• W3204043873 hasAuthorship W3204043873A5041397505 @default.
• W3204043873 hasAuthorship W3204043873A5049376976 @default.
• W3204043873 hasAuthorship W3204043873A5050863726 @default.
• W3204043873 hasAuthorship W3204043873A5050931179 @default.
• W3204043873 hasAuthorship W3204043873A5051805189 @default.
• W3204043873 hasAuthorship W3204043873A5058644407 @default.
• W3204043873 hasAuthorship W3204043873A5060227347 @default.
• W3204043873 hasAuthorship W3204043873A5060377511 @default.
• W3204043873 hasAuthorship W3204043873A5076754908 @default.
• W3204043873 hasAuthorship W3204043873A5085861845 @default.
• W3204043873 hasBestOaLocation W32040438731 @default.
• W3204043873 hasConcept C118552586 @default.
• W3204043873 hasConcept C126322002 @default.
• W3204043873 hasConcept C141071460 @default.
• W3204043873 hasConcept C142724271 @default.
• W3204043873 hasConcept C168563851 @default.
• W3204043873 hasConcept C1862650 @default.
• W3204043873 hasConcept C203092338 @default.
• W3204043873 hasConcept C204787440 @default.
• W3204043873 hasConcept C27081682 @default.
• W3204043873 hasConcept C27415008 @default.
• W3204043873 hasConcept C2776937108 @default.

• next